NTAGI

Interview: ‘India Needs To Buy Monkeypox Vaccines To Address Urgent Needs’

Exclusive: Nobody Approved India’s COVID-19 ‘Precautionary’ Doses

The Union Government Has Lied to the Supreme Court in COVID Vaccines Case

NTAGI Panel Recommends Covovax for 12-17 Age Group in Vaccination Drive

Gap Between Second and Booster Dose of COVID Vaccine Will Soon Be 6 Months

India Announces Boosters for All Adults. But Whom Will They Really Benefit?

NTAGI To Review Covovax Data This Week